Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine

αSMA

alpha smooth muscle actin

ARCON

accelerated radiotherapy with carbogen and nicotinamide

CAF

cancer-associated fibroblast

cfDNA

circulating-free DNA

CPS

combined positive score

CTC

circulating tumor cells

ctDNA

circulating tumor DNA

CTLA-4

cytotoxic T lymphocyte antigen 4

DAHANCA

Danish Head and Neck Cancer Group

DDR1

discoidin domain receptor 1

EGFR

epidermal growth factor receptor

EMA

European Medicines Agency

EMT

epithelial-to-mesenchymal transition

EORTC

European Organization for Research and Treatment of Cancer

FAP

fibroblast activation protein

FAZA

18F-fluoroazomycin arabinoside

FDA

Food and Drug Administration

FDG

18F-fluoro-2-deoxy-D-glucose

FGF

fibroblast growth factor

FGFR

fibroblast growth factor receptor

HGF

hepatocyte growth factor

HIF

hypoxia-inducible factor

MATH

mutant allele tumor heterogeneity

MCAM

melanoma cell adhesion molecule

MCT

monocarboxylate transporter

MRI

magnetic resonance imaging

NGS

next-generation sequencing

OPSCC

oropharyngeal squamous cell carcinoma

OSCC

oral squamous cell carcinoma

OXPHOS

oxidative phosphorylation

PBMC

peripheral blood mononuclear cell

PD-1

programmed cell death-1

PD-L1

programmed cell death ligand 1

PDTO

patient-derived tumor organoid

PDTX

patient-derived tumor xenograft

PET

positron emission tomography

PFS

progression-free survival

SCCHN

squamous cell carcinoma of the head and neck

scRNA-seq

single-cell RNA sequencing

TAM

tumor-associated macrophage

TAZ

transcriptional coactivator with PDZ-binding motif

TCGA

The Cancer Genome Atlas

TGF-β

transforming growth factor beta

TIGIT

T cell immunoglobin and immunoreceptor tyrosine based inhibitory motif

TiME

tumor immune microenvironment

TMB

tumor mutational burden

TME

tumor microenvironment

TPS

tumor proportion score

YAP

Yes-associated protein 1

留言 (0)

沒有登入
gif